Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Go Back to All Clinical Trials

Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Mestastic Germ Cell
Age: Between 11 Year(s) - 45 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Patients who have confirmed germ cell tumour and primary arising in testis, ovary, retro-peritoneum, or mediastinum.
2. Patients who have metastatic disease or non-testicular primary.

You may not be eligible for this study if the following are true:

1. Patients who have other primary malignancy and previous chemotherapy or radiotherapy.
2. Patients who have significant cardiac disease resulting in inability to tolerate IV fluid hydration.
3. Patients who have significant co-morbid respiratory disease that contraindicate the use of bleomycin.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies